Abstract
Introduction
Beta-blockers are widely prescribed for the treatment of cardiovascular diseases [1] [2] [3] . They inhibit β-adrenergic receptors and are classified into three generations according to their selectivity: i) first generation include the non-selective because they block both β1 and β2 receptors; ii) second generation have a selective action on β1 receptors, and iii) third generation are either selective or non-selective and have a vasodilator action 4 . Atenolol is a second generation beta-blocker which selectively competes with noradrenaline through β1 receptors leading to a negative chronotropic effect 5 . This can be verified either at rest or during exercise 1, [6] [7] [8] [9] [10] [11] . Heart rate (HR) has been widely used for exercise prescription and monitoring, mainly due to its easy applicability and low cost 12 . Because there is a reduction in the chronotropic effect during exercise in patients using beta-blockers, HR cannot be adopted for exercise prescription in hypertensives using this medication [13] [14] [15] . Therefore, patients are recommended to perform an ergometric test under the effect of beta-blockers 16 . However, since atenolol has a half-life of 4-8 hours and duration of action of 1.8 to 2.2 ml/min.kg 17, 18 , all exercise performed at a different time from the ergometric test might result in different chronotropic responses. This has been confirmed in a previous study of our laboratory 19 . Because this was the first study to demonstrate different HR responses during exercise according to the time of the administration of the beta-blocker, further studies concerning the mechanisms underlying this response need to be conducted. The autonomic modulation on the different heart rate responses during and after plasma half-life should be clarified.
Since beta-blockers act directly on adrenergic receptors, differences in HR can be caused by changes in cardiac autonomic modulation, which regulates heart rate. Thus, further studies should analyze the effects of this medication, not only on HR, but also on its regulative mechanisms -cardiac autonomic modulation. Hence, the objective of this study was to investigate the autonomic modulation and the chronotropic response during exercise in hypertensive adults using atenolol.
Materials and methods

Subjects
Twenty-five adult women were divided in three groups as follows: 1) atenolol (9 hypertensives, 54.9±5.5 years old, using atenolol, 25 mg/ day); 2) enalapril (8 hypertensives, 55,6±5,2 years old, using enalapril, a angiotensin-converting enzyme inhibitor, 5.0 mg/day) and 3) control (8 normotensives, 55,6± 6.1 years old). As inclusion criteria all subjects: a) were engaged in an aerobic exercise program for at least six months, 3-5 times a week; b) had body mass index (BMI) lower than 30.0 kg/m 2 ; c) were free from other chronic diseases; and d) had to take only one dose of the medication per day in the morning. e) women volunteers in the study were postmenopausal.
All subjects showed negative results for myocardial ischemia and arrhythmia on previous ergometric test. Based on the results of the ergometric test, the participants were classified as "weak", according to the American Heart Association. All volunteers were oriented not to drink alcohol and/or stimulants (tea, coffee, among others) 24 hours before the tests, have a good night's sleep and a light meal at least 2 hours before the test.
This research was performed in accordance with the Helsinki declaration. The research protocols were reviewed and approved by the Human Research Ethics Committee of the Federal University of Paraíba (UFPB-PB), Brazil (process nº. 0420-08).
Study design
All groups performed two exercise sessions on a cycloergometer with a 48-hour interval between them. Session I was performed two hours after the administration of the medication (dur- ing the plasma half-life period), and session II was performed 23 hours after the administration of the medication (after the plasma half-life period).
These periods were defined considering that the half-life of atenolol is 4 to 8 hours and its maximum plasma concentration is 2 hours 17, 18 according to the information in the bulla of the manufacturer of this drug. All subjects were asked to take the medication at 7 a.m., and initiate the sessions 2 and 23 hours after taking the medication (sessions I and II, respectively). Thus, all participants performed session I at 9 a.m. and session II at 6 a.m. Before, during and after exercise sessions, was made an electrocardiogram to determine the heart rate and autonomic nervous activity by spectral analysis of ECG.
Electrocardiogram
Electrocardiogram (ECG) was obtained by the connection of an electrocardiograph to a signal amplifier (General Purpose Amplifier/ Stemtech, Inc., GPA-4, model 2), which converts analog to digital signal. Following, the signal was stored in a computer in the WINDAQ DI200 software (DATAQ Instruments -Akron, Oshio, USA), which performs spectral analyses of the ECG. All data were recorded in a microcomputer with sample frequency of 500 Hz per channel.
ECG was recorded at rest, during exercise, and post-exercise. In order to record ECG at rest, subjects remained in supine position for 10 minutes. After this, signals were obtained in the same period of time. Electrocardiogram during exercise was recorded for 40 minutes, five minutes after the onset of exercise. ECG post-exercise was recorded for 10 minutes, after subjects remained in supine position for 10 minutes.
Respiratory rate
Respiratory rate was obtained with the respiratory belt (pneumographic), which contains bilateral sensors that pick up the sign breathing through the thoracic distensibility, from the respiratory pattern. The sign of breathing was preamplified (General Purpose Amplifier/Stemtech, Inc. GPA-4 model 2), and converted from analog to digital. In real time, the sign of breathing was stored in a computer program through WinDaq DI200, a frequency of 500 Hz. The respiratory rate was recorded at the same moments as the ECG, in order that the interpolation of the series tachogram and respirogram remove undesirable distortions in the spectral analysis.
Assessment of the autonomic control
Windaq PLAYBACK /DATAQ algorithm was used for the spectral analysis of heart rate variability. This program performs the withdrawal of linear tendency and the fast Fourier transform, which was applied in single window, in the sequence of R-R intervals, with the minimum of 256 consecutive beats.
Spectral powers were quantified in the very low-(VLF: < 0.04 Hz), low-(LF: 0.04-0.15 Hz) and high frequency (HF: 0.15-0.4 Hz) bands. In this study, low frequency (LF) and high frequency (HF) spectral components were used since they best represent sympathetic and vagal components of HR control, respectively. These components were reported in normalized units (LF nu and HF nu ), which represent the relative value of each power component in proportion to the total power minus the VLF component. Such components were also expressed as ratio (LF/HF), as markers of the sympathetic-vagal balance 20, 21 .
Exercise protocol
This study was conducted in an acclimatized room (temperature of around 23 ºC and relative humidity of around 54%). Forty-eight hours before experimental sessions, subjects were progressively familiarized with the equipments, research members, environment, evaluation, and tests.
Familiarization included an 8-15 minutes session to determine the load and cadence in the cycloergometer (ERGOFIT 167 cycles, Germany) in order to reach intensity between 13 and 14 of Borg's perceived exertion scale.
In both experimental sessions, exercise on cycloergometer lasted 40 minutes. Intensity was determined according to the load and cadence obtained in the familiarization session for each subject.
Assessment of blood pressure
A stethoscope and an aneroid sphygmomanometer (Missouri-Brazil), 2.0 mmHg precision were used to measure blood pressure (BP). BP was measured at rest, during exercise and post-exercise. BP at rest was assessed after supine position for 10 minutes. BP during exercise was measured at 20 and 40 minutes. To perform the measurement of 20 minutes, the researchers asked the subjects who did not interrupt the exercise. For the measurement of 40 minutes, the participants were informed that the exercise was over, but kept riding until the arterial pressure measurement was completed. BP postexercise was measured at 10, 20 and 30 minutes after exercise when subjects remained resting, adopting 30 minutes as reference.
Statistical analysis
Data were presented as mean and standard deviation. Smirnov-kolmogorov test was applied to test normality of the data. Due to this result, analysis of variance (ANOVA) was applied with Tukey's post hoc test in order to identify the differences between groups. Student T test was applied to verify the differences of each group between sessions I and II, adopting reliability level of 95%. GraphPad Instat version 3.0 software was used.
Results
Anthropometric characteristics and HR of the groups are presented in Table 1 . Age and BMI were similar between groups (p>0.05).
Resting HR of atenolol was significantly lower than enalapril in the exercise session performed during the plasma half-life period (session I) (p<0.05). In session II, in which exercise was performed after beta-blockade, resting HR was similar between groups (p>0.05).
The Figure 1 shows that the heart rate during exercise during beta-blockade (session I) was 10.6% lower than after beta-blockade (session II), (p<0.05). In both exercise sessions, HR responses were similar between enalapril and control (p>0.05). After intra-groups analyses in session I, HR during exercise in atenolol was lower than in enalapril and control (p< 0.01). There were no differences between groups in session II (p>0.05). Mean and standard deviation of autonomic modulation, including LF and HF, and autonomic balance spectral components for atenolol, enalapril and control at rest are presented in Table 2 . There were no significant differences between sessions I and II for any of the three spectral components. In session I, there was a lower resting autonomic balance in atenolol during beta-blockade than in control (p<0.05).
LF nu, HF nu, and LF/HF spectral components were similar between sessions I and II during exercise (p>0.05) ( Table 3) . Similarly, during the recovery period, there were no intra-groups differences for any spectral components (Table 4 ). Autonomic modulation and chronotropic activity during aerobic exercise in patients using atenolol
Discussion
The results of this study showed that heart rate chronotropic responses to exercise are lower during plasma half-life of atenolol (session I) compared with exercise performed after atenolol beta-blockade (session II). Concomitant with the reduction of HR, there was a greater vagal activity during atenolol beta-blockade than in control at rest. However, no differences in the autonomic balance were observed in atenolol during and after plasma half-life of atenolol.
Because atenolol is a cardio selective betablocker of β 1 receptors, it significantly reduces HR in 20% during exercise 8 . In our study, a 10.6% reduction of HR was found during plasma half-life of atenolol (session II). These data are in agreement with previous studies of our laboratory, that observed a 10.9% and 10.3% decrease of HR during exercise during atenolol betablockade compared with 11 and 23 hours of the administration of atenolol and propranolol, respectively 19 . With metropolol, a second generation beta-blocker, a 5.4 % decrease in HR during an aerobic exercise session was found during beta-blockade 22 . In hypertensive patients, the use of atenolol competes with noradrenalin by the β1receptors in the cardiac muscle 5 . Thus, the internal environment in the sinoatrial node remains more negative, keeping the sinus rhythm with lack of sympathetic stimulation, leading to a negative chronotropic effect 23 . Therefore, even if the central sympathetic stimulus remains high, its effects over the cardiac modulation are minimized. Thus, the autonomic balance obtained by spectral analysis allows the investigation of this effect. In this study, atenolol presented a significantly lower autonomic balance at rest than control, showing a higher parasympathetic activity in hypertensive patients and a higher sympathetic activity in the normotensive adults (control). However, there were no changes in autonomic balance during and after exercise neither between enalapril and control nor between during and after atenolol beta-blockade.
Hence, this work shows the following hypothesis concerning the use of beta-blockers by hypertensive patients engaged in an exercise program: a) the beta-blocker decreases resting HR; b) however, if the exercise is performed after beta-blockade, there is a lower inhibition of the positive chronotropic effect induced by the exercise. Our laboratory is the first to highlight the beta-blocker effect in hypertensive patients engaged in an exercise program; c) although HR during exercise is lower during beta-blockade, the autonomic modulation remains unchanged during exercise performed during and after beta-blockade.
The lower resting HR in subjects using beta-blockers was followed by a predominance of vagal nervous activity. These results are in agreement with previous studies that showed an association between the use of beta-blockers and the decrease of morbidity and mortality rates. This might be due to an increase of the parasympathetic activity 24, 25 . The main finding in the present study is that there are differences in the chronotropic responses during aerobic exercise during and after plasma half-life of atenolol. This is as important issue since several medical societies have recommended that hypertensives using beta-blockers should perform an ergometric test under the effect of this medication to correct the maximal HR for exercise prescription 16 . Nevertheless, according to our findings, we can assure that this measure is not completely satisfactory, because the reduction of HR during and after beta-blockade is not the same. Therefore, the time between the administration of the beta-blocker and the exercise needs to be considered when prescribing exercise for hypertensive patients.
Although the increase in the parasympathetic predominance explains the lower resting HR of subjects using beta-blockers, the lower HR during exercise during beta-blockade was not accompanied by changes in cardiac autonomic modulation. It was probably caused because, during exercise, several mechanisms are strongly activated to supply the demands caused by exercise. Thus, this acute exercise demands overtake the effects of atenolol on autonomic modulation. Similarly, the autonomic balance of post-exercise was measured at 20 minutes of recovery. It is probable that, at this time, the acute exercise responses also overtake the autonomic balance induced by the beta-blocker.
Due to the lack of association between the autonomic balance and the lower chronotropic activity during exercise performed during the beta-blockade, further studies should be conducted in order to investigate other possible mechanisms underlying this phenomenon. It is important to note that temperature and humidity, as well as the cadence and load of the cycloergometer were controlled in this study, eliminating, thus, the influences of these factors in the difference of the heart rate between both sessions. And also, these differences were not caused by hormonal influences, since no differences were found in control and enalapril.
Then, the results in the present study confirm the negative chronotropic effect of betablockers in hypertensive women. This effect is attenuated after the plasma half-life period. Therefore, more attention should be taken when prescribing exercise training for hypertensive patients after beta-blockade. Thus, the time interval between beta-blocker administration and exercise should be considered. The analysis of autonomic modulation demonstrates that the continuous use of beta-blockers benefits the cardiac autonomic function in hypertensive patients, protecting them against the development of other pathologies. We conclude, however, that no significant changes were observed in the autonomic modulation between both sessions, which suggests that future research shall to investigate other factors that can contribute to a lower HR in hypertensive patients.
